Contact Us

PIECES

The PIECES project aims to adapt and implement existing evidence-based programmes to improve implementation outcomes and by that, improve the reach and effectiveness of primary prevention programmes in real-world settings. It will address a wide range of risk factors and focus on the specific behaviour change mechanisms that promote healthy behaviours associated with a reduction of cancer incidence among the European Union (EU) population and beyond.

4P-CAN

4P-CAN’s mission is to understand barriers, whether legislative, socio-economic, commercial, or behavioural to the widespread adoption of cancer primary prevention measures across Central and Eastern Europe. By understanding barriers to policy implementation and individual adherence to healthy behaviours, 4P-CAN will improve primary prevention activities and reduce inequalities. With the collaboration of 17 organizations from 11 countries, including both EU and non-EU Balkan countries, as well as Western EU countries, 4P-CAN is dedicated to achieving these goals and fostering a healthier future.

PREVENT

PREVENT is a collaborative action to improve and upscale primary prevention of cancer by addressing childhood obesity. Through diligent implementation research and a comprehensive approach, this project aims to lay the foundation for a future where healthier lifestyles and brighter tomorrows await every child. The PREVENT project mission is rooted in epidemiological studies that have highlighted a clear link between obesity and increased risks of various types of cancer, including colon, endometrium, postmenopausal breast, and kidney cancer, among others.

ONCODIR

The research project ONCODIR will identify risk factors associated with colorectal cancer and will integrate multidisciplinary research methods and technologies (including health policy analytics, artificial intelligence and decision support theories) to deliver evidence-based and personalized recommendations on colorectal cancer prevention. ONCODIR is developing a platform based on artificial intelligence and privacy principles. It will provide recommendation services based on input from citizens, clinicians and policy-makers. The project will consider factors such as lifestyle, nutrition and economics.

Cancer Prevention at Work

The Cancer Prevention at Work (CPW) project researches the cost-effectiveness and social acceptance of incorporating prevention of cancers associated with Helicobacter pylori, Hepatitis C virus and Human Papillomavirus into ongoing primary occupational health surveillance programmes. The project involves workers and their families, policymakers, occupational health organizations, health authorities, companies and workers’ representatives, and cancer and patient organisations, among others, to identify the best strategies to increase the adherence of the population of workers in screening programs of infection-related cancers.

Co-CAPTAIN

Co-CAPTAIN project aims to address disparities in care for people with mental illness in Europe through innovative solutions such as the Patient Navigation Model. This approach focuses on patient empowerment, removing systemic barriers and ensuring access to primary prevention services. With the collaboration of experts and local governments, the project uses scientific approaches to reduce the burden of cancer and improve the overall health of people with mental health problems, reducing costs in health and social care systems in Europe. In addition, it aims to integrate integrated cancer care pathways and provide policy recommendations at European level.

Carina Dantas

Carina Dantas has a degree in Law, she is a PhD candidate on Biomedical Sciences (AI ethics) and is the CEO of SHINE 2Europe.
She is the Chair of the COST Action NET4Age-Friendly, currently gathering over 700 participants from 51 countries, and Director of the SHAFE Foundation – Smart Healthy Age-friendly Environments.
Carina is involved in many cancer-related initiatives, namely:
• WP1 Leader of RadioVal | International Clinical Validation of Radiomics Artificial Intelligence for Breast Cancer Treatment Planning
• Task leader on social innovation and stakeholder engagement in Liveration | Unravelling the impact of radiofrequency in liver surgery
• Co-researcher of EUonQol | Quality of Life in Oncology
• Member of the Portuguese National Cancer Hub – Survivors’ group
• Stakeholder Board Member of JANE Joint Action | EU Networks of Expertise on cancer
• Advisory Board member of 4P-CAN | Personalised cancer primary prevention
• Smartcare project stakeholder | Empowering Cancer Survivors in Europe
She is evaluator/reviewer for the European Commission, Eureka, AAL, EIT Climate and EIT Digital Advisory and manages several international projects such as SIRENE | Social Innovation Responsive Environments NETwork, a HORIZON Europe CSA, where she is the Project Coordinator.

Prof. Bettina Borisch

Bettina Borisch is a distinguished professor em at the Institute of Global Health, University of Geneva, and a leading figure in global public health. With an educational background in medicine and history from the Universities of Kiel and Lausanne, she has seamlessly blended her expertise in histopathology with a deep commitment to public health issues. Dr. Borisch’s career is marked by her role as head of the Institute of Clinical Pathology at the University of Geneva in 1995 and her significant contributions to breast cancer programs, notably with the Swiss Cancer League.
Transitioning to public health, she oriented her activities towards addressing global health challenges. Dr. Borisch is at the forefront of health communication and community-based oncology, leveraging her position as Executive Director of the World Federation of Public Health Associations to foster international collaborations. Her editorial roles in leading health journals and her involvement in public health committees reflect her influence in shaping health policies and practices.
Previously, she held the prestigious position of president of Europa Donna – The European Breast Cancer Forum and was the Founding President of the Swiss Forum of Europa Donna. Dr. Borisch is also a dedicated educator, teaching at the University of Geneva, the Swiss School of Public Health, and patient support groups, emphasizing the importance of knowledge transfer in public health.
Overall, her work, characterized by scientific rigor and a humanistic approach, is driven by a comprehensive understanding of health, from the microscopic to the global level.

Prof. Hajo Zeeb 

Hajo Zeeb is currently leading the Department of Prevention and Evaluation at the BIPS (Leibniz Institute for Prevention Research and Epidemiology) since January 2010, has significantly contributed to the field of implementation research and living labs within public health. After his medical training at RWTH Aachen in Germany, followed by clinical practice in Germany and the UK, and a stint as a medical officer in Northern Namibia, he furthered his expertise with a Master’s in Public Health from Heidelberg University.
His work at the German Cancer Research Center and the University of Bielefeld involved him in numerous epidemiological studies, also allowing him to share his knowledge through teaching, especially in the MSc Epidemiology program.
His tenure with the WHO’s Department of Public Health and Environment in Geneva, and later as a Professor of Epidemiology at Mainz University, underpinned his commitment to public health challenges, particularly those related to environmental radiation. Prof. Zeeb’s involvement in international and national scientific organizations, the German Radiation Protection Commission, and the scientific advisory board of the Bernhard Nocht Institute for Tropical Medicine, alongside his role in the German UNSCEAR delegation, showcases his multifaceted engagement with health sciences.
Since 2019, as the Co-Speaker of the “Health Sciences” research area at the University of Bremen and the head of the Leibniz Science Campus Digital Public Health Bremen, Prof. Zeeb has been instrumental in harnessing digital innovations to advance public health initiatives, emphasizing the role of living labs and implementation research in transforming health outcomes. He is also contributing to IARC’s current work to develop the 5th edition of the European Code Against Cancer.

Our cookie policy

We use cookies or similar technologies for technical purposes and, with your consent, for other purposes as specified in the cookie policy. Denying consent may make related features unavailable.

Use the “Accept & Close” button to consent. Use the “Decline” button or close this notice to continue without accepting.

To find out more, read our cookies and privacy policy.